行情

ELGX

ELGX

恩多勒吉克斯
NASDAQ

实时行情|Nasdaq Last Sale

2.030
+0.070
+3.57%
休市 16:00 01/17 EST
开盘
1.960
昨收
1.960
最高
2.120
最低
1.940
成交量
27.35万
成交额
--
52周最高
8.95
52周最低
1.550
市值
3,642.24万
市盈率(TTM)
-0.3045
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ELGX 新闻

  • Those Who Purchased Endologix (NASDAQ:ELGX) Shares Five Years Ago Have A 99% Loss To Show For It
  • Simply Wall St..01/10 13:19
  • Endologix, Inc. to Present at the J.P. Morgan Healthcare Conference
  • Business Wire.01/02 21:01
  • The Daily Biotech Pulse: Canadian Approval For Amarin's Vascepa, Innate Pharma's Blood Cancer Drug Accepted For Review In Europe
  • Benzinga.01/02 13:52
  • Hedge Funds Are Dumping Endologix, Inc. (ELGX)
  • Insider Monkey.2019/12/20 23:20

更多

所属板块

医疗设备、用品及经销
+0.07%
医疗设备和用品
+0.29%

热门股票

名称
价格
涨跌幅

ELGX 简况

Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company's products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). It offers accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths.
展开

Webull提供Endologix, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。